Development of the Theracyte Cellular Encapsulation System for Delivery of human ES Cell-derived Pancreatic Islets and Progenitors.

  • Post author:
  • Post category:

There are several challenges to the successful implementation of a cellular therapy for insulin dependent diabetes derived from Human Embryonic Stem Cells (hESCs). Among these are the development of functional…

Continue ReadingDevelopment of the Theracyte Cellular Encapsulation System for Delivery of human ES Cell-derived Pancreatic Islets and Progenitors.

Development of an hES Cell-Based Assay System for Hepatocyte Differentiation Studies and Predictive Toxicology Drug Screening

  • Post author:
  • Post category:

Drug-induced liver toxicity, including that from FDA-approved drugs, is the leading cause of liver failure in the US. One of the biggest road blocks to testing drug-induced liver toxicity prior…

Continue ReadingDevelopment of an hES Cell-Based Assay System for Hepatocyte Differentiation Studies and Predictive Toxicology Drug Screening

Molecular dissection of adult liver regeneration to guide the generation of hepatocytes from pluripotent stem cells

  • Post author:
  • Post category:

The liver is a promising target for cell therapy since it supports and functionally integrates transplanted cells. Human liver contains more than 50 billion cells and more than 10% replacement…

Continue ReadingMolecular dissection of adult liver regeneration to guide the generation of hepatocytes from pluripotent stem cells

Cell Therapy for Diabetes

  • Post author:
  • Post category:

Diabetes exacts a tremendous toll on patients, their families, and society in general. Autoimmune Type 1 diabetes, often called juvenile-onset diabetes, is caused by a person’s own immune system mistakenly…

Continue ReadingCell Therapy for Diabetes

Immune cloaking of human stem cell-derived insulin-producing cells for curative cell therapy without immunosuppression

  • Post author:
  • Post category:

Research Objective The goal of our project is to generate cells for replacement therapy in patients that have reduced ability to trigger the immune response in the recipient and therefore…

Continue ReadingImmune cloaking of human stem cell-derived insulin-producing cells for curative cell therapy without immunosuppression